

LL-37
LL-37 is the active 37-residue peptide released from human cathelicidin (hCAP18), and the only cathelicidin-derived antimicrobial peptide identified in humans.
It is amphipathic and cationic, allowing it to interact with negatively charged microbial membranes, and it is studied both as an antimicrobial agent in vitro and as a signaling molecule involved in innate immune responses.
- Compound class
- Synthetic research compound
- Research category
- Immune & Inflammatory
- SKU
- NVR-LL-37-5MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
More detail on LL-37.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
LL-37 is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.